238 related articles for article (PubMed ID: 12173917)
1. "Hook effect" in prolactinomas: case report and review of literature.
Frieze TW; Mong DP; Koops MK
Endocr Pract; 2002; 8(4):296-303. PubMed ID: 12173917
[TBL] [Abstract][Full Text] [Related]
2. Falsely low serum prolactin in two cases of invasive macroprolactinoma.
Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G
Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675
[TBL] [Abstract][Full Text] [Related]
3. The hook effect in prolactin immunoassays.
Al Sifri SN; Raef H
Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
[TBL] [Abstract][Full Text] [Related]
4. Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect": case report.
Barkan AL; Chandler WF
Neurosurgery; 1998 Apr; 42(4):913-5; discussion 915-6. PubMed ID: 9574657
[TBL] [Abstract][Full Text] [Related]
5. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
[TBL] [Abstract][Full Text] [Related]
6. A predictive algorithm for evaluating elevated serum prolactin in patients with a sellar mass.
Cheng JS; Salinas R; Molinaro A; Chang EF; Kunwar S; Blevins L; Aghi MK
J Clin Neurosci; 2015 Jan; 22(1):155-60. PubMed ID: 25481269
[TBL] [Abstract][Full Text] [Related]
7. Update on prolactinomas. Part 2: Treatment and management strategies.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
[TBL] [Abstract][Full Text] [Related]
8. Giant prolactinomas presenting as skull base tumors.
Minniti G; Jaffrain-Rea ML; Santoro A; Esposito V; Ferrante L; Delfini R; Cantore G
Surg Neurol; 2002 Feb; 57(2):99-103; discussion 103-4. PubMed ID: 11904200
[TBL] [Abstract][Full Text] [Related]
9. Ten-year follow-up of a giant prolactinoma.
Fernandes V; Santos MJ; Almeida R; Marques O
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26590188
[TBL] [Abstract][Full Text] [Related]
10. Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
Levin G; Rottenstreich A
Hormones (Athens); 2019 Jun; 18(2):137-139. PubMed ID: 30341577
[TBL] [Abstract][Full Text] [Related]
11. [Some issues in the diagnosis and treatment of hyperprolactinemia].
Jin ZM
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
[No Abstract] [Full Text] [Related]
12. Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1562-7. PubMed ID: 26256063
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Hamilton DK; Vance ML; Boulos PT; Laws ER
Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinaemia in males: a heterogeneous disorder.
Walsh JP; Pullan PT
Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
16. Invasive Giant Prolactinoma.
Alkhaibary A; Alharbi A; Khairy S
World Neurosurg; 2024 Jan; 181():21-22. PubMed ID: 37827431
[TBL] [Abstract][Full Text] [Related]
17. Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?
Alkabbani AG; Mon SY; Hatipoglu B; Kennedy L; Faiman C; Weil RJ; Hamrahian AH
Pituitary; 2014 Apr; 17(2):97-102. PubMed ID: 23468127
[TBL] [Abstract][Full Text] [Related]
18. Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.
Tamagno G; Daly AF; Deprez M; Vroonen L; Andris C; Martin D; Beckers A
Ann Endocrinol (Paris); 2008 Feb; 69(1):47-52. PubMed ID: 18082643
[TBL] [Abstract][Full Text] [Related]
19. Giant prolactinomas, a detailed analysis of 196 adult cases.
Lisa B; Arno V; Christophe B; Heyning Paul V; Carlien H
Pituitary; 2023 Oct; 26(5):529-537. PubMed ID: 37544978
[TBL] [Abstract][Full Text] [Related]
20. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas.
St-Jean E; Blain F; Comtois R
Clin Endocrinol (Oxf); 1996 Mar; 44(3):305-9. PubMed ID: 8729527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
